The proinflammatory mediator macrophage migration inhibitory factor induces glucose catabolism in muscle

Journal of Clinical Investigation

Volumn 106, Issue 10, 2000, Pages 1291-1300

  Benigni, Fabio ^a   Atsumi, Toshiya ^a   Calandra, Thierry ^a,b   Metz, Christine ^a   Echtenacher, Bernd ^c   Peng, Tina ^a   Bucala, Richard ^a  

^a PICOWER INST FOR MEDICAL RESEARCH   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY OF REGENSBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

6 PHOSPHOFRUCTO 2 KINASE; FRUCTOSE 2,6 BISPHOSPHATASE; FRUCTOSE 2,6 BISPHOSPHATE; GLUCOSE; INSULIN; LACTIC ACID; MACROPHAGE MIGRATION INHIBITION FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOCRINE EFFECT; CELL ACTIVATION; CONTROLLED STUDY; ENZYME SYNTHESIS; GLUCOSE BLOOD LEVEL; GLYCOLYSIS; HYPOGLYCEMIA; IMMUNE RESPONSE; INSULIN RELEASE; MEDIATOR RELEASE; METABOLIC REGULATION; MOUSE; MUSCLE METABOLISM; MYOTUBE; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0033677088     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI9900     Document Type: Article

References (57)

1. Metabolism of sepsis and multiple organ failure
2. Mammalian 6-phosphofructo-2-kinase/frucrose-2,6-bisphosphatase: A bifunctional enzyme that controls glycolysis
3. Acute and chronic exposure to tumor necrosis factor-α fails to affect insulin-stimulated glucose metabolism of isolated rat soleus muscle
4. TNFα has no direct in vivo metabolic effect on human muscle
5. Tumor necrosis factor-α: A key component of the obesity-diabetes link
6. Increased adipose tissue expression of rumor necrosis factor-α in human obesity and insulin resistance
7. Mechanism of a reaction in vitro associated with delayed-type hypersensitivity
8. Delayed hypersensitivity in vitro: Its mediation by cell-free substances formed by lymphoid cell-antigen interaction
9. Molecular cloning of a cDNA encoding human macrophage migration inhibitory factor
10. Macrophage migration inhibitory factor (MIF) is a pituitary-derived cytokine that potentiates lethal endotoxaemia
11. The macrophage is an important and previously unrecognized source of macrophage migration inhibitory factor (MIF)
12. An essential regulatory role for macrophage migration inhibitory factor in T-cell activation
13. Macrophage migration inhibitory factor (MIF) is a critical mediator of the activation of immune cells by exotoxins of Gram-positive bacteria
14. Protection from septic shock by neutralization of macrophage migration inhibitory factor
15. Migration inhibitory factor (MIF) expression in experimentally induced endotoxemia
16. Human circulating eosinophils secrete macrophage migration inhibitory factor (MIF). Potential role in asthma
17. MIF as a glucocorticoid-induced counter-regulator of cytokine production
18. Localization of macrophage migration inhibitory factor (MIF) to secretory granules within the corticotrophic and thyrotrophic cells of the pituitary gland
19. Insulin secretion is regulated by the glucose-dependent production of islet beta cell macrophage migration inhibitory factor
20. Purification, bioactivity, and secondary structure analysis of mouse and human macrophage migration inhibitory factor (MIF)
21. The structure and physicochemical properties of rat liver macrophage migration inhibitory factor
22. Regulatory role for macrophage migration inhibitory factor (MIF) in acute respiratory distress syndrome
23. Sustained mitogen-activated protein kinase (MAPK) and cytoplasmic phospholipase A2 activation by macrophage migration inhibitory factor (MIF)
24. A kinetic study of pyrophosphate: Fructose-6-phosphate phosphotransferase from potato tubers. Application to a microassay of fructose 2,6-bisphosphate
25. Cytokines modulate glucose transport in skeletal muscle by inducing the expression of inducible nitric oxide synthase
26. The enzymatic carboxylation of phosphoenolpyruvate. II. Purification and properties of liver mitochondrial phosphoenolpyruvate carboxykinase
27. Influence of endotoxin treatment on dexamethasone induction of hepatic phosphoenolpyruvate carboxykinase
28. The contribution of gluconeogenesis to glycogen repletion during glucose infusion in endotoxemia
29. Fructose 2,6-bisphosphate and the control of glycolysis by growth factors, tumor promoters and oncogenes
30. Effect of endotoxin-induced monokines on glucose metabolism in the muscle cell line L6
31. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: Role in tumor cell glycolysis and the Warburg effect
32. Cachecrin/TNFα-mediated lactate production in cultured myocytes is linked to activation of a futile substrate cycle
33. Correlation between fructose 2,6-bisphosphate and lactate production in skeletal muscie
34. Effect of tumor necrosis factor-α on basal and insulin-stimulared glucose transport in cultured muscle and fat cells
35. TNF-α stimulates glucose uptake in L6 myoblasts
36. Effects of tumor necrosis factor-α on glucose metabolism in cultured human muscle cells from nondiabetic and type 2 diabetic subjects
37. Effect of minor necrosis factor-alpha on insulin action in cultured rat skeletal muscle cells
38. TNF-α impairs insulin signaling and insulin stimulation of glucose uptake in C2C12 muscle cells
39. Insulin-like growth factor-I improves glucose utilization in tumor necrosis factor-treated rats under hyperinsulinemic-euglycemic conditions
40. Tumor necrosis factor-α inhibits leptin production in subcutaneous and omental adipocytes from morbidly obese humans
41. Tumor necrosis factor inhibits the transcriptional rate of glucose-6-phosphatase in vivo and in vitro
42. Tumor necrosis factor: An updated review of its biology
43. Tumor necrosis factor enhances glucose uptake by peripheral tissues
44. Tumor necrosis factor mimics the metabolic response to acute infection in healthy humans
45. Lethal hypoglycemia and hypothermia induced by administration of low doses of tumor necrosis factor to adrenalectomized rats
46. Chronic intraperitoneal infusion of low doses of minor necrosis factor-γ in rats induces a reduction in plasma triglyceride levels
47. Tumor necrosis factor acutely increases plasma levels of very low density lipoproteins of normal size and composition
48. Studies on the mechanisms underlying adaptive changes in rat liver phosphoenolpyruvate carboxykinase
49. Human recombinant IL-1 alters glucocorticoid receptor function in Reuber hepatoma cells
50. Effects of tumour necrosis factor-α (TNFα) on glucose transport and lipid metabolism of newly-differentiated human fat ceils in cell culture
51. Targeted disruption of migration inhibitory factor gent reveals its critical role in sepsis
52. Glucocorticoids induce the expression of macrophage migration inhibitory factor (MIF) in vivo
53. MIF rediscovered: Cytokine, pituitary hormone, and glucocorticoid-induced regulator of the immune response
54. The pathogenic role of macrophage migration inhibitory factor (MIF) in immunologically induced kidney disease in the rat
55. Macrophage migration inhibitory factor (MIF) is involved in the pathogenesis of collagen type II-induced arthritis in mice
56. Macrophage migration inhibitory factor in rheumatoid arthritis
57. MIF mediation of sepsis